Network Researchers Database

Clustering approaches to unravel complex asthma phenotypes ——- Validation of genetic associations in asthma and allergy in Canadian families

Better Exposure Avoidance Measures (BEAM)

Legal Rights and Allergy Policy

Can e-health tools improve health outcomes in asthma?

Towards evidence-based, consensus-driven food allergen risk management framework

Canadian Group of Food Allergy Research (CanGoFAR) ——- Canadian Group on Food Allergy Research (CanGoFAR) ——- Disease Management: Canadian peanut thresholds study ——- Identification of genetic predictors of peanut allergy ——- Predicting Peanut Allergy ——- Preventing Severe reactions – Preclinical Studies ——- Regulation of lung mucosal immune responses by heterologous exposure to multiple infectious and allergic agents ——- Strategies for enhancing tolerance induction: Preclinical studies and CHILD linked project development —— Investigation of Strategies to Dismantle Persistent Peanut Allergy

Causes and Prevention: Identifying the genetic basis of peanut allergy

A Cross-Canada Anaphylaxis Registry (C-CARE) ——- Cross-Canada Anaphylaxis REgistry (C-CARE) ——- Is the prevalence of peanut allergy increasing? A five-year follow-up study on the prevalence of peanut allergy in Montreal school children, aged 5-9 ——- SPAACE Surveying Prevalence of food Allergies in All Canadian Environments ——- Surveying Canadians to Assess the Prevalence of Common Food Allergies and Attitudes towards Food Labelling and Risk (SCAAALAR) ——- Surveying the Prevalence of food Allergy in All Canadian Environments -Trends Over Time (SPAACE to SPAACE) ——- The development, implementation and evaluation of strategies to promote well-being of children and youth with allergies and/or asthma (Part 2 THEME B – Improving Food Labelling for Allergens to Build Consumer Capacity)

Is the prevalence of peanut allergy increasing? A five-year follow-up study on the prevalence of peanut allergy in Montreal school children, aged 5-9 ——- The development, implementation and evaluation of strategies to promote well-being of children and youth with allergies and/or asthma (Part 2 THEME B – Improving Food Labelling for Allergens to Build Consumer Capacity)

Can e-health tools improve health outcomes in asthma? ——- Development of an Evidence-based Certified Allergy Educator Program

Allergy-Brain Connection (ABC) Research Team

Validation of genetic associations in asthma and allergy in Canadian families

Development of human dendritic cell immunotherapy for treatment of asthma and allergy

Certified Allergy Educator Program ——- Functional consequences of innate immune receptor polymorphisms —— Improving Oral Food Challenge (OFC) Implementation in Canada

Can e-health tools improve health outcomes in asthma?

Evidence, ethics and health policy research

Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Development of a standardized nasal allergen challenge model for a multi-center research collaborative to investigate novel therapeutic agents for allergic rhinitis ——- Development of an Adaptive Immune Phenotyping Monitoring Platform ——- The Clinical Investigator Collaborative (CIC)-Allergic Rhinitis (AR) ——- The link between upper and lower airway inflammation —— Nasal allergen challenge – reproducibility of biomarkers and effect of topical steroid treatment

Role of mast cells and eosinophils in allergic inflammationand fibrosis of the lung

Asthma and BC workers ——- Surveillance of occupational asthma

Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies

Development of an Evidence-based Certified Allergy Educator Program

Engaging Aboriginal families affected by allergies and asthma in support-education program development ——- Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies

Let Them Eat Dirt: The Hunt for Our Kids’ Missing Microbes

Environmental impact on the epithelial immune barrier in asthma ——- Functional TSLP genomics in vitro and ex vivo: human epithelial cell production of TSLP in relation to asthma development

Evidence, ethics and health policy research

The Canadian Healthy Infant Longitudinal Development (CHILD) Study

Mini-CHILD: Psychosocial Assessment and Epigenetics ——- An Integrative Multidimensional Genomic and Epigenomic Approach for the Study of Short-Term Diesel Exhaust on Asthmatics ——- Developmental plasticity and fetal programming of asthma in mice ——- Rapid Environmental Effects on Genes: The Lens of Epigenetics (REEGLE) ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500 —— Strengthening the Case for Ongoing Reduction of Exposure to Traffic-Related Air Pollution (SCORE-TRAP) —— Better Exposure Avoidance Measures (BEAM)

Asthma and BC workers

Towards evidence-based, consensus-driven food allergen risk management framework

Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies

Vaccines for asthma & allergies – a bacterial immune-prophylactic and therapeutic approach ——- An Assessment of Long-Term Indoor Residential Pollution Exposures among Canadian Children ——- Development of an Adaptive Immune Phenotyping Monitoring Platform ——- Expansion of existing capacity of immunology platform to support Canadian Healthy Infant Longitudinal Development study (birth cohort) ——- Functional genetics in allergy ——- Improved Tools for Assessing Long-Term Indoor and Outdoor Exposures in Epidemiologic Studies of Allergy and Asthma & Repeat Home Visits and Alternative Sampling Techniques in the Mini-CHILD Study (Mini-CHILD II) ——- Mini-CHILD: Assessment of the home environment ——- Mini-CHILD: Recruitment ——- Neuroimmune interactions: a partnership in drug development and translational research ——- Ontogeny and genetic polymorphisms of the innate immune system intersecting in asthma ——- Rapid Environmental Effects on Genes: The Lens of Epigenetics (REEGLE) ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500

Causes and Prevention: Identifying the genetic basis of peanut allergy ——- Traffic-related air pollution as a risk factor for the development of childhood asthma —— Causes and Prevention: Identifying the genetic basis of peanut allergy

Maternal Stress and Childhood Asthma ——- Allergy-Brain Connection (ABC) Research Team ——- Clustering approaches to unravel complex asthma phenotypes ——- Financial barriers to medication use in children with asthma: Effect on health outcomes ——- Genome wide association study of allergy and asthma in the Canadian Asthma Primary Prevention Study (CAPPS) and the Study of Allergy Genes and Environment (SAGE) ——- Genome-wide Association Results ——- Maternal distress and the development of atopic disease in children: Potential pathways and interventions ——- Postpartum Distress and Childhood Asthma: The Genetics, and the Social and Ethical Impacts of this Genetic Association ——- Stress, asthma and atopy socio-spatial investigations (SAASSI) ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study ——- TLR function in human neonates ——- Traffic-related air pollution as a risk factor for the development of childhood asthma ——- Validation of genetic associations in asthma and allergy in Canadian families —— Project 500

Role of mast cells and eosinophils in allergic inflammationand fibrosis of the lung

Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting ——- Workplace sensitizers: skin and lung exposure, responses and prevention ——- Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

The Canadian Healthy Infant Longitudinal Development (CHILD) Study

Investigation of Strategies to Dismantle Persistent Peanut Allergy

A Cross-Canada Anaphylaxis Registry (C-CARE) ——- Cross-Canada Anaphylaxis REgistry (C-CARE) ——- Surveying the Prevalence of food Allergy in All Canadian Environments -Trends Over Time (SPAACE to SPAACE) —— The Economic Impact of Food Allergy in Canada —— Towards evidence-based, consensus-driven food allergen risk management framework

A Cross-Canada Anaphylaxis Registry (C-CARE)

Functional consequences of innate immune receptor polymorphisms

Canadian Group of Food Allergy Research (CanGoFAR) ——- Canadian Group on Food Allergy Research (CanGoFAR) ——- Identification of genetic predictors of peanut allergy ——- Modulation of exocytosis in allergic inflammation

Mobilizing best practices in Asthma and Allergy management and use of the Air Quality Health Index in the Canadian sport and recreation community

An Integrative Multidimensional Genomic and Epigenomic Approach for the Study of Short-Term Diesel Exhaust on Asthmatics

Towards evidence-based, consensus-driven food allergen risk management framework

An Assessment of Long-Term Indoor Residential Pollution Exposures among Canadian Children ——- Improved Tools for Assessing Long-Term Indoor and Outdoor Exposures in Epidemiologic Studies of Allergy and Asthma & Repeat Home Visits and Alternative Sampling Techniques in the Mini-CHILD Study (Mini-CHILD II)

Identification of genetic predictors of peanut allergy ——- Canadian Group on Food Allergy Research (CanGoFAR) ——- Clustering approaches to unravel complex asthma phenotypes ——- Functional genetics in allergy ——- Functional TSLP genomics in vitro and ex vivo: human epithelial cell production of TSLP in relation to asthma development ——- Genome wide association study of allergy and asthma in the Canadian Asthma Primary Prevention Study (CAPPS) and the Study of Allergy Genes and Environment (SAGE) ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study ——- Validation of genetic associations in asthma and allergy in Canadian families —— Project 500

Clinical Investigator Collaborative (CIC) ——- Development of an Adaptive Immune Phenotyping Monitoring Platform ——- Functional genetics in allergy ——- Functional genomic and proteomic changes in response to nasal allergen challenge and following peptide immunotherapy treatment of the same: A partnership with the Allergic-Rhinitis Clinical Investigator Collaborative (AR-CIC) and industry ——- Hemopoietic stem cell biomarkers in the diagnosis and prediction of allergic inflammation and disease ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study ——- The Clinical Investigator Collaborative (CIC)-Allergic Rhinitis (AR) ——- Vaccines for asthma & allergies – a bacterial immune-prophylactic and therapeutic approach —— Biomarker development for monitoring responses in CIC clinical trials

Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Development of an Evidence-based Certified Allergy Educator Program ——- Enhancing RAP for First Nations Communities ——- Extending the Reach: From Practice to Evidence ——- Mobilizing best practices in Asthma and Allergy management and use of the Air Quality Health Index in the Canadian sport and recreation community ——- Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies ——- Sustainable Online Support for Children and Adolescents Affected by Asthma and Allergies

Clinical Investigator Collaborative (CIC)

Study of the pathogenesis and reversibility of airway damage and repair during chronic mucosal immune responses to environmental allergies

The Clinical Investigator Collaborative (CIC)-Severe Asthma

Surveying the Prevalence of food Allergy in All Canadian Environments -Trends Over Time (SPAACE to SPAACE)

Causes and Prevention: Identifying the genetic basis of peanut allergy

Knowledge Mobilization for the CHILD Study

Shared Decision in Asthma Management: A Strategy to Improve Asthma Control

Clinical Investigator Collaborative (CIC) ——- The Clinical Investigator Collaborative (CIC)-Allergic Asthma (AA) ——- The Clinical Investigator Collaborative (CIC)-Severe Asthma —— Nebulizer assessment for sputum induction —— Markers of Inflammation – Development and Optimization of Assays —— Knowledge Mobilization for the CIC —— Mannitol-Induced Cough Challenge in Healthy Controls and Subjects with Mild Allergic Asthma

Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting ——- The Clinical Investigator Collaborative (CIC)-Severe Asthma ——- Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Develop and implement an allergen-gene environment database resource

Allergy-Brain Connection (ABC) Research Team ——- Building continuity of support for allergic children with asthma and/or anaphylaxis and their families ——- Engaging Aboriginal families affected by allergies and asthma in support-education program development ——- Maternal distress and the development of atopic disease in children: Potential pathways and interventions ——- Postpartum Distress and Childhood Asthma: The Genetics, and the Social and Ethical Impacts of this Genetic Association ——- Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies ——- Stress, asthma and atopy socio-spatial investigations (SAASSI) ——- Sustainable Online Support for Children and Adolescents Affected by Asthma and Allergies

Can e-health tools improve health outcomes in asthma? ——- Certified Allergy Educator Program ——- Development of an Evidence-based Certified Allergy Educator Program ——- Mobilizing best practices in Asthma and Allergy management and use of the Air Quality Health Index in the Canadian sport and recreation community ——- Online Certificate Course in Best Practices for Allergic Disease/Anaphylaxis for Schools ——- Pharmacogenetics & Genetic Testing 3D graphical animation tool

A Cross-Canada Anaphylaxis Registry (C-CARE)

Functional consequences of innate immune receptor polymorphisms

Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting ——- Workplace sensitizers: skin and lung exposure, responses and prevention ——- Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Cardiopulmonary consequences of air pollution in a murine model of allergic asthma —— Better Exposure Avoidance Measures (BEAM)

CHILD Executive Meeting Workshop in Toronto ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study ——- Project 500

Can e-health tools improve health outcomes in asthma? ——- Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting ——- Technology-enabled Knowledge Translation and Mobilization ——- Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Study of the pathogenesis and reversibility of airway damage and repair during chronic mucosal immune responses to environmental allergies

Asthma and BC workers ——- Parental preferences for asthma control in children ——- Platform for Outcomes Research and Translation in Asthma and allergy (PORTAL) ——- Technology-enabled Knowledge Translation and Mobilization ——- The Platform for Outcomes Research and Translation in Asthma and Allergy (PORTAL)

A network biology approach to allergy requires annotated database of molecular interaction

Evidence, ethics and health policy research

Prevention and management of adverse reactions to food in schools—a systematic review and practice guidelines

Nasal allergen challenge – reproducibility of biomarkers and effect of topical steroid treatment

Maternal Stress and Childhood Asthma ——- Stress, asthma and atopy socio-spatial investigations (SAASSI)

Neuroendocrine regulation of allergic reactions in animal models: Translation to humans

The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500

Building continuity of support for allergic children with asthma and/or anaphylaxis and their families

Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Allergy-Brain Connection (ABC) Research Team ——- CHILD Executive Meeting Workshop in Toronto ——- Maternal distress and the development of atopic disease in children: Potential pathways and interventions ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500 —— Knowledge Mobilization for the CHILD Study —— Identifying Childhood Sleep-Disordered Breathing (SDB) phenotypes using Urine Metabolomics

Gender-related biologic and sociologic impact of obesity

Urine Metabolomics Analysis for Asthma Diagnosis

Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting

Causes and Prevention: Identifying the genetic basis of peanut allergy

Consumer Preference for Allergen Food Labelling ——- Platform for Outcomes Research and Translation in Asthma and allergy (PORTAL) 

Non-invasive diagnosis: Metabolics for the various phenotypes of asthma (formerly: Diagnosing the Various Phenotypes of Asthma: The Use of Urine NMR)

Canadian Group on Food Allergy Research (CanGoFAR) ——- Disease Management: Canadian peanut thresholds study

Cardiopulmonary consequences of air pollution in a murine model of allergic asthma

TLR function in human neonates

Canadian Group of Food Allergy Research (CanGoFAR) ——- Canadian Group on Food Allergy Research (CanGoFAR) ——- Functional consequences of innate immune receptor polymorphisms ——- Identification of genetic predictors of peanut allergy ——- Strategies for enhancing tolerance induction: Preclinical studies and CHILD linked project development ——- Technology-enabled Knowledge Translation and Mobilization ——- Tolerance induction and threshold studies to peanut allergen: relevance to consumer exposure to baked goods ——- Development of a National Food Allergy Strategy for Canada: Step 1 —— Causes and Prevention: Identifying the genetic basis of peanut allergy

Let Them Eat Dirt: The Hunt for Our Kids’ Missing Microbes

Host environment interaction: Educating TLR-4+lymphocytes in childhood ——- Study of the pathogenesis and reversibility of airway damage and repair during chronic mucosal immune responses to environmental allergies ——- The Clinical Investigator Collaborative (CIC)-Severe Asthma

Clinical Investigator Collaborative (CIC)

The Canadian Healthy Infant Longitudinal Development (CHILD) Study

Causes and Prevention: Identifying the genetic basis of peanut allergy

Sustainable Online Support for Children and Adolescents Affected by Asthma and Allergies

Development of an Evidence-based Certified Allergy Educator Program

Building continuity of support for allergic children with asthma and/or anaphylaxis and their families ——- Engaging Aboriginal families affected by allergies and asthma in support-education program development ——- Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies ——- Sustainable Online Support for Children and Adolescents Affected by Asthma and Allergies

Neuroendocrine Regulation of Allergic Inflammation: Translational Studies ——- Neuroimmune interactions: a partnership in drug development and translational research

Clinical Investigator Collaborative (CIC)

CHILD Coordinator 3-year Clinic Training Session Workshop in Manitoba

Clinical Investigator Collaborative (CIC) ——- Genetics of the early and late responses to AllerGen challenge ——- Metabolomics ——- Non-invasive diagnosis: Metabolics for the various phenotypes of asthma (formerly: Diagnosing the Various Phenotypes of Asthma: The Use of Urine NMR) ——- Shared Decision in Asthma Management: A Strategy to Improve Asthma Control ——- The Clinical Investigator Collaborative (CIC)-Allergic Asthma (AA) —— Urine Metabolomics Analysis for Asthma Diagnosis —— Nebulizer assessment for sputum induction —— Markers of Inflammation – Development and Optimization of Assays —— Knowledge Mobilization for the CIC —— Improved diagnosis of asthma: metabolomics —— Mannitol-Induced Cough Challenge in Healthy Controls and Subjects with Mild Allergic Asthma

Disease Modulation Clinical Tolerance Study ——- Environmental impact, inflammation and the role of IL-13 receptor a2 ——- Host environment interaction: Educating TLR-4+lymphocytes in childhood ——- Intracellular Cytokine Production ——- Knowledge Mobilization Cafe Scientifique on the top of allergies (food and drug) ——- Vaccines for asthma & allergies – a bacterial immune-prophylactic and therapeutic approach —— Causes and Prevention: Identifying the genetic basis of peanut allergy

Hemopoietic stem cell biomarkers in the diagnosis and prediction of allergic inflammation and disease

Canadian Group on Food Allergy Research (CanGoFAR)

Building a collaborative working group to inform the development of a National Lung Health Framework (NLHF) Phase II ——- Building continuity of support for allergic children with asthma and/or anaphylaxis and their families ——- Development of an Evidence-based Certified Allergy Educator Program ——- Engaging Aboriginal families affected by allergies and asthma in support-education program development ——- Evaluation of the Implementation and Effectiveness of Statutory and Regulatory Based Policies for Anaphylaxis Risk Reduction ——- Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies ——- Shared Decision in Asthma Management: A Strategy to Improve Asthma Control ——- Sustainable Online Support for Children and Adolescents Affected by Asthma and Allergies ——- The Roaring Adventures of Puff: A school-based asthma education program

Respiratory syncytial virus in the development of infant wheezing disorders: a bench to bedside approach to gene-virus interactions

Can e-health tools improve health outcomes in asthma?

Food Allergy Management at University from the Perspective of Students and Food Service Management

Asthma and BC workers

Allergic Asthma functional & Pharmaco-genomics for Early and Late Phase Response Biomarkers —— Biomarker development for monitoring responses in CIC clinical trials

Blocking Human CD34 Expression as a Therapeutic for Mucosal Inflammatory Disease ——- Canadian Group of Food Allergy Research (CanGoFAR) ——- Canadian Group on Food Allergy Research (CanGoFAR) ——- CD34 as a therapeutic target for allergic inflammation and asthma ——- Environmental Affects on Allergic Airway Disease ——- Hemopoietic stem cell biomarkers in the diagnosis and prediction of allergic inflammation and disease ——- Identification of genetic predictors of peanut allergy ——- Role of mast cells and eosinophils in allergic inflammationand fibrosis of the lung ——- Strategies for enhancing tolerance induction: Preclinical studies and CHILD linked project development ——- The distribution and function of FceR1 on nerves ——- Vaccines for asthma & allergies – a bacterial immune-prophylactic and therapeutic approach —— CD34 as a Therapeutic Target for Allergic Asthma —— Cytof-enabled biomarkers of allergic disease —— Markers of Inflammation – Development and Optimization of Assays —— Stem Cell Team for Emerging BioMarkers —— Strengthening the Case for Ongoing Reduction of Exposure to Traffic-Related Air Pollution (SCORE-TRAP)

Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies

Let Them Eat Dirt: The Hunt for Our Kids’ Missing Microbes

Cardiopulmonary consequences of air pollution in a murine model of allergic asthma

Evidence, ethics and health policy research

Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Evidence, ethics and health policy research

Neuroendocrine Regulation of Allergic Inflammation: Translational Studies

Stress, asthma and atopy socio-spatial investigations (SAASSI)

CHILD Executive Meeting Workshop in Toronto ——- Mini-CHILD: Psychosocial Assessment and Epigenetics ——- Psycho-social Assessment and Epigenetics: Mini-CHILD ——- Rapid Environmental Effects on Genes: The Lens of Epigenetics (REEGLE) ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500

Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting

Allergic Asthma CIC

Role of mast cells and eosinophils in allergic inflammationand fibrosis of the lung

A Cross-Canada Anaphylaxis Registry (C-CARE)

Building continuity of support for allergic children with asthma and/or anaphylaxis and their families

IDO, glutamate receptors and allergic inflammation ——- Metabolomics ——- Non-invasive diagnosis: Metabolics for the various phenotypes of asthma (formerly: Diagnosing the Various Phenotypes of Asthma: The Use of Urine NMR) ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study

Respiratory syncytial virus in the development of infant wheezing disorders: a bench to bedside approach to gene-virus interactions ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500

A Cross-Canada Anaphylaxis Registry (C-CARE)

TLR function in human neonates

Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Hemopoietic stem cell biomarkers in the diagnosis and prediction of allergic inflammation and disease

Validation of genetic associations in asthma and allergy in Canadian families

Antenatal steroid therapy for fetal lung maturation: Is there an association with childhood asthma

Development of human dendritic cell immunotherapy for treatment of asthma and allergy

The Clinical Investigator Collaborative (CIC)-Severe Asthma —— Urine Metabolomics Analysis for Asthma Diagnosis —— Knowledge Mobilization for the CIC —— Improved diagnosis of asthma: metabolomics

Mini-CHILD: Environmental assessment of molecular genetic characterization of microbes in outdoor and indoor air and dust

Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Development of a standardized nasal allergen challenge model for a multi-center research collaborative to investigate novel therapeutic agents for allergic rhinitis ——- Functional genomic and proteomic changes in response to nasal allergen challenge and following peptide immunotherapy treatment of the same: A partnership with the Allergic-Rhinitis Clinical Investigator Collaborative (AR-CIC) and industry ——- The Clinical Investigator Collaborative (CIC)-Allergic Rhinitis (AR) —– Biomarker development for monitoring responses in CIC clinical trials

Evidence, ethics and health policy research

Clinical Investigator Collaborative (CIC) ——- Biomarkers of a Sympathetic Anti-inflammatory Pathway, Neuro-regulation of Sympathetic Anti-inflammatory Activity ——- Can e-health tools improve health outcomes in asthma? ——- CHILD Executive Meeting Workshop in Toronto ——- CIC Quality Assurance Plan ——- CIC Quality Assurance Plan ——- CIC Quality Assurance Plan ——- CIC Quality Assurance Plan Statistical Analyses ——- CIC Quality Assurance Plan Statistical Analyses ——- Development of a Microarray Genotyping Chip for Clinical Trials ——- Development of an Adaptive Immune Phenotyping Monitoring Platform ——- Genetics of the early and late responses to AllerGen challenge ——- Hemopoietic stem cell biomarkers in the diagnosis and prediction of allergic inflammation and disease ——- Neuroendocrine Regulation of Allergic Inflammation: Translational Studies ——- Neuroimmune interactions: a partnership in drug development and translational research ——- Technology-enabled Knowledge Translation and Mobilization ——- The Clinical Investigator Collaborative (CIC)-Allergic Asthma (AA) ——- Thymic Stromal Lymphopoitin-induced Cord Blood Hemopoietic Progenitors: Biomarkers for the Development of Atopy and Asthma —— Nebulizer assessment for sputum induction —— CIC Mediator Library —— Methacholine challenge: comparison of airway responsiveness between vibrating mesh and jet nebulizer aerosol generation —— Knowledge Mobilization for the CIC —— Mannitol-Induced Cough Challenge in Healthy Controls and Subjects with Mild Allergic Asthma

A Cross-Canada Anaphylaxis Registry (C-CARE)

White Paper Series

Development of an Adaptive Immune Phenotyping Monitoring Platform

Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting ——- Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

Causes and Prevention: Identifying the genetic basis of peanut allergy

Evidence, ethics and health policy research

Allergic asthma: Air pollution and allergen interactions ——- Cardiopulmonary consequences of air pollution in a murine model of allergic asthma

Validation of genetic associations in asthma and allergy in Canadian families

Stem Cell Team for Emerging BioMarkers

Validation of genetic associations in asthma and allergy in Canadian families ——- Functional TSLP genomics in vitro and ex vivo: human epithelial cell production of TSLP in relation to asthma development ——- Genome wide association study of allergy and asthma in the Canadian Asthma Primary Prevention Study (CAPPS) and the Study of Allergy Genes and Environment (SAGE) ——- Genome-wide Association Results ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study

Changing Practice for Prevention and Early Detection of Occupational Asthma and Allergic Diseases in the Primary Care Setting

Traffic-related air pollution as a risk factor for the development of childhood asthma

The Clinical Investigator Collaborative (CIC)-Severe Asthma

Developmental plasticity and fetal programming of asthma in mice

Environmental impact, inflammation and the role of IL-13 receptor a2

Legal Rights and Allergy Policy

Disease Modulation Clinical Tolerance Study

Developmental plasticity and fetal programming of asthma in mice ——- Perinatal stress and programming of allergic responses

Development of an Educational Program on Asthma and Associated Respiratory Disorders Adapted for High-Level Athletes

A Cross-Canada Anaphylaxis Registry (C-CARE)

Infant Inflammatory Markers and Lung Function ——- Mini-CHILD: Development of objective measurement of airway inflammation and lung function in infants

Hemopoietic stem cell biomarkers in the diagnosis and prediction of allergic inflammation and disease ——- Hemopoietic stem cells as biomarkers of atopy, airways inflammation, and sources of

Workplace sensitizers: skin and lung exposure, responses and prevention

Development of human dendritic cell immunotherapy for treatment of asthma and allergy

Genetics of the early and late responses to AllerGen challenge

Cardiopulmonary consequences of air pollution in a murine model of allergic asthma

Food Allergy Management at University from the Perspective of Students and Food Service Management

The Canadian Healthy Infant Longitudinal Development (CHILD) Study

Infant Inflammatory Markers and Lung Function ——- Mini-CHILD: Development of objective measurement of airway inflammation and lung function in infants ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500

Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): Development of a standardized nasal allergen challenge model for a multi-center research collaborative to investigate novel therapeutic agents for allergic rhinitis ——- Genetics of the early and late responses to AllerGen challenge ——- Metabolomics

Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies

Functional consequences of innate immune receptor polymorphisms

Respiratory syncytial virus in the development of infant wheezing disorders: a bench to bedside approach to gene-virus interactions

Moving forward with birth cohort research in Canada: The legal and ethical foundations for the CHILD study ——- White Paper Series

Work-Related Asthma and Allergy: Prevention and Early Detection (WRAAPED) research program

The Canadian Healthy Infant Longitudinal Development (CHILD) Study

Cardiopulmonary consequences of air pollution in a murine model of allergic asthma ——- Environmental Affects on Allergic Airway Disease

Biomarkers of a Sympathetic Anti-inflammatory Pathway, Neuro-regulation of Sympathetic Anti-inflammatory Activity —— Studies of CABS1 as a Biomarker and Potential Therapeutic Agent for Stress

The distribution and function of FceR1 on nerves

Towards evidence-based, consensus-driven food allergen risk management framework

TLR function in human neonates

Studies of CABS1 as a Biomarker and Potential Therapeutic Agent for Stress

Development of a Mobile Application for Food Allergic Children & Teens

Cross-Canada Anaphylaxis REgistry (C-CARE) ——- Metabolomics ——- Non-invasive diagnosis: Metabolics for the various phenotypes of asthma (formerly: Diagnosing the Various Phenotypes of Asthma: The Use of Urine NMR) ——- Urine NMR-based Metabolomics for Asthma Diagnosis —— Urine Metabolomics Analysis for Asthma Diagnosis

Development of an Evidence-based Certified Allergy Educator Program ——- Mobilizing best practices in Asthma and Allergy management and use of the Air Quality Health Index in the Canadian sport and recreation community

The Platform for Outcomes Research and Translation in Asthma and Allergy (PORTAL) —— Strengthening the Case for Ongoing Reduction of Exposure to Traffic-Related Air Pollution (SCORE-TRAP)

SPAACE Surveying Prevalence of food Allergies in All Canadian Environments

Causes and Prevention: Identifying the genetic basis of peanut allergy ——- CHILD Executive Meeting Workshop in Toronto ——- Development of a Microarray Genotyping Chip for Clinical Trials ——- Environmental impact, inflammation and the role of IL-13 receptor a2 ——- Functional genetics in allergy ——- Functional TSLP genomics in vitro and ex vivo: human epithelial cell production of TSLP in relation to asthma development ——- Genome wide association study of allergy and asthma in the Canadian Asthma Primary Prevention Study (CAPPS) and the Study of Allergy Genes and Environment (SAGE) ——- Genome-wide Association Results ——- Identification of genetic predictors of peanut allergy ——- Mini-CHILD: AllerChip – Development, Validation and Implementation of a Microarray Genotyping Tool for Allergy and Asthma Research ——- Respiratory syncytial virus in the development of infant wheezing disorders: a bench to bedside approach to gene-virus interactions ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study ——- Validation of genetic associations in asthma and allergy in Canadian families —— Project 500

Enhancing RAP for First Nations Communities

Better Exposure Avoidance Measures (BEAM)

Surveillance of occupational asthma

An Assessment of Long-Term Indoor Residential Pollution Exposures among Canadian Children ——- Better Exposure Avoidance Measures (BEAM) and New Environmental Sensor Tool Development ——- Environmental impact, inflammation and the role of IL-13 receptor a2 ——- Improved Tools for Assessing Long-Term Indoor and Outdoor Exposures in Epidemiologic Studies of Allergy and Asthma & Repeat Home Visits and Alternative Sampling Techniques in the Mini-CHILD Study (Mini-CHILD II) ——- Mini-CHILD: Assessment of the home environment ——- Mini-CHILD: Environmental assessment of molecular genetic characterization of microbes in outdoor and indoor air and dust ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study —— Project 500

The Canadian Healthy Infant Longitudinal Development (CHILD) Study

CHILD Coordinator 3-year Clinic Training Session Workshop in Manitoba ——- CHILD Executive Meeting Workshop in Toronto ——- CHILD Operating Grant ——- Development of an Evidence-based Certified Allergy Educator Program ——- Infant Inflammatory Markers and Lung Function ——- Mini-CHILD: Environmental assessment of molecular genetic characterization of microbes in outdoor and indoor air and dust ——- Technology-enabled Knowledge Translation and Mobilization ——- The Canadian Healthy Infant Longitudinal Development (CHILD) Study ——- Project 500 —— Knowledge Mobilization for the CHILD Study —— Rapid Environmental Effects on Genes: The Lens of Epigenetics (REEGLE)

Promoting Health Equity for Vulnerable Populations affected by Asthma and Allergies

Clinical Investigator Collaborative (CIC) —— Markers of Inflammation – Development and Optimization of Assays —— The Clinical Investigator Collaborative (CIC)-Allergic Asthma (AA) —— The Clinical Investigator Collaborative (CIC)-Severe Asthma —— Nasal allergen challenge – reproducibility of biomarkers and effect of topical steroid treatment